These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 5502005

  • 21. [Apropos of the current status of sensitivity of frequent pathogens of urinary tract infections to nitrofurantoin].
    Legler F.
    Arzneimittelforschung; 1965 Mar; 15(3):299-300. PubMed ID: 5897224
    [No Abstract] [Full Text] [Related]

  • 22. Pivmecillinam in uncomplicated urinary tract infections in general practice.
    Peddie BA, Little PJ.
    N Z Med J; 1981 Feb 25; 93(678):109-11. PubMed ID: 6267530
    [No Abstract] [Full Text] [Related]

  • 23. [Microbial sensitivity to various antibacterials, including nalidixic acid. 2,458 Gram negative bacilli strains of diverse origins, especially urinary].
    Chamfeuil R, Curcier H.
    Therapeutique; 1969 Oct 25; 45(8):757-62. PubMed ID: 5386084
    [No Abstract] [Full Text] [Related]

  • 24. [Drug-resistant organisms in urinary tract infections and clinical use of Wintomylon (nalidixic acid)].
    Kuze M, Kashiwagi T, Okita J, Komiya T, Nihira H.
    Hinyokika Kiyo; 1966 Mar 25; 12(3):291-6. PubMed ID: 6006673
    [No Abstract] [Full Text] [Related]

  • 25. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R, Allocati N, Catamo G.
    Chemioterapia; 1984 Jun 25; 3(3):167-72. PubMed ID: 6241505
    [Abstract] [Full Text] [Related]

  • 26. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
    Esposito S, Galante D, Pennucci C, Barba D, Limauro D, Scioli C.
    Chemioterapia; 1984 Jun 25; 3(3):196-9. PubMed ID: 6241506
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
    Sweet RL, Ohm-Smith MJ, Hadley WK.
    J Antimicrob Chemother; 1982 Dec 25; 10(6):553-7. PubMed ID: 6219085
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Use of nalidixic acid (Wintomylon) for the treatment of urinary tract infections].
    Ohori T, Koshiba K, Goto Y, Ujiie K, Kasahara N.
    Hinyokika Kiyo; 1965 Jul 25; 11(7):677-84. PubMed ID: 5319354
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical evaluation of Wintomylon (nalidixic acid) in the urinary tract infections].
    Yamasaki I, Kato T, Ogawa T.
    Hinyokika Kiyo; 1965 Sep 25; 11(9):913-34. PubMed ID: 5324475
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Sensitivity to neggram of microorganisms causing urinary tract infections].
    Fryszman J, Kossakowski J, Narbutowicz B, Soldaj H.
    Wiad Lek; 1966 Dec 15; 19(24):1951-7. PubMed ID: 5980076
    [No Abstract] [Full Text] [Related]

  • 35. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
    de Rautlin de la Roy Y, Toma V, Bobin B.
    Curr Med Res Opin; 1978 Dec 15; 5(9):743-8. PubMed ID: 738079
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Nitrofurantoin-Nalidixic acid antagonism].
    Stille W, Ostner KH.
    Klin Wochenschr; 1966 Feb 01; 44(3):155-6. PubMed ID: 5982876
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.